
New FDA Warning Letter Issued Curaleaf Hemp Over Improper CBD Disease Claims
FDA has issued a warning letter dated July 22, 2019 against Curaleaf Hemp, online retailer of CBD products for both humans and pets, for selling unapproved and misbranded drugs. Curaleaf made improper disease claims about their products, such as “CBD has been linked to the effective treatment of Alzheimer’s disease” and “CBD was effective in…